Surfak (Docusate calcium 240 mg)

Pill imprint Surfak has been identified as Docusate calcium 240 mg.

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 240 mg is not a controlled substance under the Controlled Substance Act (CSA).

Docusate calcium

Imprint:

Surfak

Strength:

240 mg

Color:

Red

Shape:

Elliptical / Oval

Availability:

Rx and/or OTC

Drug Class:

Laxatives

Pregnancy Category:

N - Not classified

CSA Schedule:

Not a controlled drug

Manufacturer:

Chattem, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.